Citi on Tuesday became one of the first investment firms to lower its China growth forecast on escalating trade tensions with the U.S.
Related Posts
JPMorgan’s top biopharma picks for 2025
The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.
Amazon goes nuclear, to invest more than $500 million to develop small module reactors
Amazon is the latest large tech company to buy into nuclear power to fuel the growing demands from data centers.
Super Micro shares plunge 35% as auditor resigns after raising concerns months earlier
Ernst & Young resigned over accounting and governance concerns at the buzzy AI firm, which has faced regulatory scrutiny before.